Morgan Stanley - Dec 31, 2024 SCHEDULE 13G/A Report for UroGen Pharma Ltd. Ordinary Shares (URGN)

Filing Manager: MORGAN STANLEY
Reporting Manager: Morgan Stanley
Security: UroGen Pharma Ltd. Ordinary Shares
Symbol: URGN
Shares outstanding: 41.8M shares
Disclosed Ownership: 753K shares
Ownership: 1.8%
Form type: SCHEDULE 13G/A
Date filed: 2/5/2025, 10:09 AM
Date of event: Dec 31, 2024
Next filing: Aug 6, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Morgan Stanley	1.8%	753K	0	748K	Christopher O'Hara	Authorized Signatory, Morgan Stanley